Quick Answer
QuidelOrtho Corp reported Total Revenue of $2.73 billion for fiscal year 2025.
QuidelOrtho Corp — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $2.73B -1.9% |
$2.78B -7.2% |
$3.00B -8.2% |
$3.27B +92.3% |
$1.70B +2.2% |
$1.66B |
| Net Income | -$1.13B +44.8% |
-$2.05B -20216.8% |
-$10.10M -101.8% |
$548.70M -22.1% |
$704.20M -13.1% |
$810.30M |
| Diluted EPS | -$16.69 +45.4% |
-$30.54 -20260.0% |
-$0.15 -101.6% |
$9.56 -41.8% |
$16.43 -11.7% |
$18.60 |
| Total Assets | $5.77B -10.2% |
$6.42B -25.0% |
$8.56B -3.3% |
$8.86B +264.4% |
$2.43B | — |
| Cash and Equivalents | $169.80M +72.7% |
$98.30M -17.3% |
$118.90M -59.4% |
$292.90M -63.5% |
$802.80M | — |
| Stockholders Equity | $1.92B -35.7% |
$2.98B -40.4% |
$5.01B +1.4% |
$4.93B +155.8% |
$1.93B +44.8% |
$1.33B +138.0% |
| R&D Expense | $186.20M -14.9% |
$218.70M -10.7% |
$245.00M +30.4% |
$187.90M +96.3% |
$95.70M +13.5% |
$84.30M |
| Operating Income | -$919.20M +53.1% |
-$1.96B -1509.7% |
$139.10M -83.5% |
$843.70M -6.9% |
$906.00M -14.6% |
$1.06B |
| Shares Outstanding | 67.90M +0.9% |
67.30M +0.9% |
66.70M +0.5% |
66.40M +59.2% |
41.70M | — |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $699.90M | -3.7% | +14.0% |
| Net Income | September 30, 2025 | -$733.00M | -3583.4% | -187.0% |
| Diluted EPS | September 30, 2025 | -$10.78 | -3493.3% | -185.9% |
| Total Assets | September 30, 2025 | $5.68B | -16.6% | -11.0% |
| Cash and Equivalents | September 30, 2025 | $98.10M | -31.7% | -35.3% |
| Stockholders Equity | September 30, 2025 | $2.04B | -36.1% | -27.1% |
| R&D Expense | September 30, 2025 | $41.50M | -25.8% | -9.2% |
| Operating Income | September 30, 2025 | -$704.80M | -4798.7% | -290.0% |
| Shares Outstanding | September 30, 2025 | 67.90M | +1.0% | +0.3% |
- QuidelOrtho Corp reported Total Revenue of $2.73 billion for fiscal year 2025.
- QuidelOrtho Corp showed a decrease of -1.9% in Total Revenue compared to the prior fiscal year.
- QuidelOrtho Corp reported Net Income of -$1.13 billion for fiscal year 2025.
- QuidelOrtho Corp showed an increase of +44.8% in Net Income compared to the prior fiscal year.
- QuidelOrtho Corp reported Diluted EPS of $16.69 per share (loss) for fiscal year 2025.
- QuidelOrtho Corp showed an increase of +45.4% in Diluted EPS compared to the prior fiscal year.
- QuidelOrtho Corp reported Total Assets of $5.77 billion for fiscal year 2025.
- QuidelOrtho Corp showed a decrease of -10.2% in Total Assets compared to the prior fiscal year.
- QuidelOrtho Corp reported Cash and Equivalents of $169.80 million for fiscal year 2025.
- QuidelOrtho Corp showed an increase of +72.7% in Cash and Equivalents compared to the prior fiscal year.
- QuidelOrtho Corp reported Stockholders Equity of $1.92 billion for fiscal year 2025.
- QuidelOrtho Corp showed a decrease of -35.7% in Stockholders Equity compared to the prior fiscal year.
- QuidelOrtho Corp reported R&D Expense of $186.20 million for fiscal year 2025.
- QuidelOrtho Corp showed a decrease of -14.9% in R&D Expense compared to the prior fiscal year.
- QuidelOrtho Corp reported Operating Income of -$919.20 million for fiscal year 2025.
- QuidelOrtho Corp showed an increase of +53.1% in Operating Income compared to the prior fiscal year.
- QuidelOrtho Corp reported Shares Outstanding of 67.90 million shares for fiscal year 2025.
- QuidelOrtho Corp showed an increase of +0.9% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: